牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 883 shares of common stock on 02/26/2024, as per the latest filing. The shares, valued at an aggregate market value of $375,893.1, were acquired on 02/24/2024 as performance shares, a form of compensation from the issuer. This transaction follows a series of sales over the past three months, where Morrow sold a total of 2,915 shares, amounting to gross proceeds of $1,227,277.68. The planned sale is in line with a notice dated 02/26/2024, with the original plan adopted on 08/22/2023.
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 883 shares of common stock on 02/26/2024, as per the latest filing. The shares, valued at an aggregate market value of $375,893.1, were acquired on 02/24/2024 as performance shares, a form of compensation from the issuer. This transaction follows a series of sales over the past three months, where Morrow sold a total of 2,915 shares, amounting to gross proceeds of $1,227,277.68. The planned sale is in line with a notice dated 02/26/2024, with the original plan adopted on 08/22/2023.
最新文件顯示，Vertex Pharmicals Inc.高管阿特金森·愛德華·莫羅三世定於2024年2月26日出售883股普通股。這些股票的總市值爲375,893.1美元，於2024年2月24日作爲績效股票收購，這是發行人的一種薪酬。該交易是在過去三個月進行的一系列銷售之後進行的，莫羅共出售了2,915股股票，總收益爲1,227,277.68美元。計劃中的出售與2024年2月26日的通知一致，最初的計劃於2023年8月22日通過。
最新文件顯示，Vertex Pharmicals Inc.高管阿特金森·愛德華·莫羅三世定於2024年2月26日出售883股普通股。這些股票的總市值爲375,893.1美元，於2024年2月24日作爲績效股票收購，這是發行人的一種薪酬。該交易是在過去三個月進行的一系列銷售之後進行的，莫羅共出售了2,915股股票，總收益爲1,227,277.68美元。計劃中的出售與2024年2月26日的通知一致，最初的計劃於2023年8月22日通過。
有用
沒用